Read + Share
Liu W, Huo G, Chen P. Clinical benefit of pembrolizumab in treatment of first line non-small cell lung
cancer: a systematic review and meta-analysis of clinical characteristics. BMC Cancer 2023;23:458.
PMID: 37202730
|
 |
|
Liu W, Huo G, Chen P. Clinical benefit of pembrolizumab in treatment of first line non-small cell lung
cancer: a systematic review and meta-analysis of clinical characteristics. BMC Cancer 2023;23:458.
PMID: 37202730
|
|
|
|